Graf Akcie EW (Edwards Lifesciences Corp). Diskuze k akciím EW. Aktuální informace EW.

Základní informace o společnosti Edwards Lifesciences Corp (Akcie EW)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 67.44B
Hodnota podniku (EV) 72.9B
Tržby 4.925B
EBITDA 1.267B
Zisk 1.462B
Růst v tržbách Q/Q 48.76 %
Růst v tržbách Y/Y 13.96 %
P/E (Cena vůči ziskům) 47.93
Forward P/E 4.53
EV/Sales 14.80
EV/EBITDA 57.52
EV/EBIT 43.65
PEG 2.58
Price/Sales 13.69
P/FCF 64.17
Price/Book 14.74
Účetní hodnota na akcii 7.61
Hotovost na akcii 2.33
FCF vůči ceně 1.56 %
Počet zaměstnanců 14,900
Tržba na zaměstnance 330.550k
Profit margin 18.77 %
Operating margin 30.94 %
Gross margin 75.36 %
EBIT margin 33.91 %
EBITDA margin 25.73 %
EPS - Zisk na akcii 2.34
EPS - Kvartální růst 88.24 %
EPS - Očekávaný růst příští rok 5.88 %
Return on assets 20.23 %
Return on equity 31.49 %
ROIC 13.59 %
ROCE 24.65 %
Dluhy/Equity 0.58
Čistý dluh/EBITDA -2.23
Current ratio 3.75
Quick Ratio 2.89
Volatilita 2.31
Beta 0.98
RSI 46.96
Cílová cena analytiků 90
Známka akcie (dle analytiků) 2.04
Insider ownership 0.74 %
Institutional ownership 85.68 %
Počet akcií 623.328M
Procento shortovaných akcií 0.97 %
Short ratio 2.57 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2000
Země United States

Finanční výsledky akcie EW

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$4,386.3$4,348$3,722.8$3,435.3$2,963.7$2,493.7
Cost Of Goods Sold$1,080.6$1,114.4$939.4$875.3$797.4$617.2
Gross Profit$3,305.7$3,233.6$2,783.4$2,560$2,166.3$1,876.5
Research And Development Expenses$760.7$752.7$622.2$552.6$442.2$382.9
SG&A Expenses$1,228.4$1,242.2$1,088.5$990.8$904.7$850.7
Other Operating Income Or Expenses$-419$-91.9$-324.5$72.8$-35.6$-0.2
Operating Expenses$3,488.7$3,201.2$2,974.6$2,345.9$2,179.9$1,851
Operating Income$897.6$1,146.8$748.2$1,089.4$783.8$642.7
Total Non-Operating Income/Expense$19.1$19.7$13.2$-54.5$-45.9$-20.3
Pre-Tax Income$916.7$1,166.5$761.4$1,034.9$737.9$622.4
Income Taxes$93.3$119.6$39.2$451.3$168.4$127.5
Income After Taxes$823.4$1,046.9$722.2$583.6$569.5$494.9
Other Income------
Income From Continuous Operations$823.4$1,046.9$722.2$583.6$569.5$494.9
Income From Discontinued Operations------
Net Income$823.4$1,046.9$722.2$583.6$569.5$494.9
EBITDA$1,004.8$1,236.1$825.6$1,171.3$855$708.5
EBIT$897.6$1,146.8$748.2$1,089.4$783.8$642.7
Basic Shares Outstanding623625628633639647
Shares Outstanding632637641648653661
Basic EPS$1.32$1.68$1.15$0.92$0.89$0.77
EPS - Earnings Per Share$1.30$1.64$1.13$0.90$0.87$0.75
# 2020 2019 2018 2017 2016 2015
Current Ratio3.45793.30672.60881.79524.20664.3005
Long-term Debt / Capital0.11510.12530.1590.12910.2390.1925
Debt/Equity Ratio0.13010.14330.18910.35060.3140.2385
Gross Margin75.364274.369874.766374.520473.094475.2496
Operating Margin20.463726.375420.097831.711926.446725.773
EBIT Margin20.463726.375420.097831.711926.446725.773
EBITDA Margin22.907728.429222.176934.09628.849128.4116
Pre-Tax Profit Margin20.899226.828420.452430.125524.897924.9589
Net Profit Margin18.772124.077719.399416.988319.215919.846
Asset Turnover0.60610.67020.69930.60630.65710.6148
Inventory Turnover Ratio1.34691.73881.54761.57742.01061.8158
Receiveable Turnover7.27657.25766.92877.16737.14836.7071
Days Sales In Receivables50.161250.292452.679350.925551.060854.4199
ROE - Return On Equity18.000625.236922.997119.741621.744919.7715
Return On Tangible Equity26.823539.593842.860542.858231.849529.6454
ROA - Return On Assets11.377516.135713.565810.299312.627512.2008
ROI - Return On Investment15.928722.073919.340217.19216.54915.9645
Book Value Per Share7.327119.83885.044.69914.12573.8736
Operating Cash Flow Per Share-0.18940.412-0.09910.46690.2464-0.7387
Free Cash Flow Per Share-0.43390.3848-0.2120.4770.1321-0.7714